Natco Pharma [NATCOPHARM] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Natco Pharma Ltd.

NSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Natco Pharma Ltd. wins in 12 metrics, Sun Pharmaceutical Industries Ltd. wins in 8 metrics, with 0 ties. Natco Pharma Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Natco Pharma Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 12.32 36.73 Natco Pharma Ltd.
Price-to-Book Ratio 2.22 5.15 Natco Pharma Ltd.
Debt-to-Equity Ratio 3.01 6.68 Natco Pharma Ltd.
PEG Ratio 0.89 3.59 Natco Pharma Ltd.
EV/EBITDA 9.10 23.61 Natco Pharma Ltd.
Profit Margin (TTM) 34.13% 19.21% Natco Pharma Ltd.
Operating Margin (TTM) 17.38% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 17.38% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 24.77% 15.08% Natco Pharma Ltd.
Return on Assets (TTM) 21.85% 11.87% Natco Pharma Ltd.
Free Cash Flow (TTM) $11.85B $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield 0.73% 0.97% Sun Pharmaceutical Industries Ltd.
1-Year Return -5.35% 7.10% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 4.21 7.05 Natco Pharma Ltd.
Enterprise Value $162.40B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 3.56 6.66 Natco Pharma Ltd.
Gross Profit Margin (TTM) 79.44% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $255 $237 Natco Pharma Ltd.
Earnings per Share (Diluted) $86.97 $45.46 Natco Pharma Ltd.
Beta (Stock Volatility) 0.19 0.11 Sun Pharmaceutical Industries Ltd.

Natco Pharma Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

NATCOPHARM
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Natco Pharma Ltd.-1.89%-2.38%-29.31%-10.42%-6.36%-4.57%
Sun Pharmaceutical Industries Ltd.-0.09%0.96%-3.84%1.28%0.50%4.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Natco Pharma Ltd.-5.35%37.05%-21.16%69.86%1,522.04%4,430.15%
Sun Pharmaceutical Industries Ltd.7.10%82.23%170.41%143.23%656.74%2,541.29%

Performance & Financial Health Analysis: Natco Pharma Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricNATCOPHARMSUNPHARMA
Market Information
Market Cap i₹191.91B₹3.88T
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i701,4643,903,142
90 Day Avg. Volume i888,1693,253,866
Last Close₹847.60₹1,806.00
52 Week Range₹789.00 - ₹1,226.80₹1,548.00 - ₹1,916.60
% from 52W High-30.91%-5.77%
All-Time High₹1,639.00 (Sep 09, 2024)₹1,960.35 (Sep 30, 2024)
% from All-Time High-48.29%-7.87%
Growth Metrics
Quarterly Revenue Growth0.36%0.14%
Quarterly Earnings Growth0.14%0.16%
Financial Health
Profit Margin (TTM) i0.34%0.19%
Operating Margin (TTM) i0.17%0.26%
Return on Equity (TTM) i0.25%0.15%
Debt to Equity (MRQ) i3.016.68
Cash & Liquidity
Book Value per Share (MRQ)₹482.88₹324.46
Cash per Share (MRQ)₹178.93₹115.87
Operating Cash Flow (TTM) i₹19.26B₹110.84B
Levered Free Cash Flow (TTM) i₹18.85B₹109.29B
Dividends
Last 12-Month Dividend Yield i0.73%0.97%
Last 12-Month Dividend i₹6.50₹16.50

Valuation & Enterprise Metrics Analysis: Natco Pharma Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricNATCOPHARM (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i12.3236.73
Forward P/E i27.2629.48
PEG Ratio i0.893.59
Price to Sales (TTM) i4.217.05
Price to Book (MRQ) i2.225.15
Market Capitalization
Market Capitalization i₹191.91B₹3.88T
Enterprise Value i₹162.40B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i3.566.66
Enterprise to EBITDA i9.1023.61
Risk & Other Metrics
Beta i0.190.11
Book Value per Share (MRQ) i₹482.88₹324.46

Financial Statements Comparison: Natco Pharma Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNATCOPHARM (2025)SUNPHARMA (2025)
Revenue/Sales i44.12B520.41B
Cost of Goods Sold i8.65B121.98B
COGS % of Revenue i19.6%23.4%
Gross Profit i35.46B398.44B
Gross Margin i80.4%76.6%
Research & Development i1.13BN/A
Operating Income (EBIT) i19.81B125.81B
Operating Margin i44.9%24.2%
EBITDA i24.58B167.25B
EBITDA Margin i55.7%32.1%
Pre-Tax Income i22.91B137.52B
Pre-Tax Income % of Revenue i51.9%26.4%
Income Tax i4.08B27.72B
Income Tax % of Revenue i9.2%5.3%
Net Income (Profit) i18.83B109.65B
Profit Margin i42.7%21.1%

Balance Sheet & Liquidity Metrics

MetricNATCOPHARM (2025)SUNPHARMA (2025)
Cash & Equivalents i1.20B102.69B
Total Current Assets i52.70B526.24B
Total Current Assets % of Revenue i119.5%101.1%
Total Current Liabilities i9.44B181.94B
Total Current Liabilities % of Revenue i21.4%35.0%
Long-Term Debt i46.00M3.58B
Long-Term Debt % of Revenue i0.1%0.7%
Total Shareholders Equity i76.12B724.86B
Retained Earnings i62.47B578.62B
Retained Earnings % of Revenue i141.6%111.2%
Property, Plant & Equipment i474.00M100.36B

Cash Flow Statement Comparison

MetricNATCOPHARM (2025)SUNPHARMA (2025)
Operating Cash Flow i19.26B110.84B
Operating Cash Flow % of Revenue i43.7%21.3%
Capital Expenditures i-3.06B-20.68B
Free Cash Flow i11.85B119.44B
FCF Margin i26.9%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase i0-29.00B

Short Interest & Institutional Ownership Analysis

MetricNATCOPHARMSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i179.11M2.40B
Float Shares i83.44M1.07B
% Held by Insiders i50.55%55.62%
% Held by Institutions i11.35%28.69%
% Held by Public i38.10%15.69%

Dividend Analysis & Yield Comparison: Natco Pharma Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricNATCOPHARMSUNPHARMA
Last 12-Month Dividend i₹6.50₹16.50
Last 12-Month Dividend Yield i0.73%0.97%
3-Year Avg Annual Dividend i₹7.25₹17.33
3-Year Avg Dividend Yield i0.24%0.51%
3-Year Total Dividends i₹21.75₹52.00
Ex-Dividend DateFeb 18, 2026Feb 05, 2026